Exelixis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.10.17	HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL (RTTNews)
16.10.17	MÄRKTE USA/Erneut Rekorde - Dow nähert sich der 23.000er Marke (Dow Jones)
16.10.17	Exelixis Remains Sharply Higher After Early Rally (RTTNews)
16.10.17	Exelixis' Cabozantinib: Trial In HCC Meets Main Goal; FDA Priority Review In RCC (RTTNews)
16.10.17	Ipsen : Phase 3 CELESTIAL Trial Of Cabozantinib Meets Primary Endpoint In HCC (RTTNews)
25.09.17	Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes (RTTNews)
11.09.17	New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch (RTTNews)
08.09.17	NLNK Rallies On Indoximod Data, VRNA Breathes Easy, ALNY Jolted (RTTNews)
28.08.17	Stock Performance Review on Biotech Industry -- Exelixis, Geron, Inovio Pharma, and Intra Cellular Therapies (PR Newswire)
24.07.17	Technical Snapshots for These Biotech Stocks -- Exelixis, Celldex Therapeutics, Clovis Oncology, and Geron (PR Newswire)
14.07.17	Company Spotlight: Exelixis (RTTNews)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
20.06.17	AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade (RTTNews)
02.05.17	Investors: Covered Call reports for Exelixis, Facebook, Priceline, Pfizer Inc. and AT&T include trade ideas that offer returns of 18% or more! (PR Newswire)
14.03.17	Biotech Stocks Under Scanner -- Gilead Sciences, Exelixis, Mast Therapeutics, and Novavax (PR Newswire)
09.03.17	Beat market volatility with these stock option trade ideas for Citigroup, Exelixis, Gilead Sciences, Tesla Motors, and US Oil Fund! (PR Newswire)
27.02.17	New Cancer Therapeutics Drive the Cancer Biological Therapy Market (PR Newswire)
01.02.17	Activision Blizzard, Exelixis, Hanesbrands Inc., Altria Group Incorporated, Vale, and more offer option-trading opportunities that offer returns of more than 18% (PR Newswire)
31.01.17	AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch (RTTNews)
12.01.17	Investors: Covered-Call Reports for BB&T Corporation, Exelixis, Merck & Company Incorporated, Parsley Energy Inc and Workday (PR Newswire)
09.01.17	Genentech Withdraws Counterclaim Against Exelixis In JAMS Arbitration (RTTNews)
05.01.17	Biotech Stocks Under Review -- Novavax, Gilead Sciences, ARIAD Pharma, and Exelixis (PR Newswire)
05.12.16	Covered Call reports for Exelixis, Alibaba, Procter & Gamble, Whiting Petroleum and GW Pharmaceuticals include trade ideas that offer returns of 20% or more! (PR Newswire)
22.11.16	InvestorsObserver releases covered-call reports for Exelixis, Valeant Pharmaceuticals, Cheniere Energy, General Electric and The Kroger Co (PR Newswire)
21.11.16	Biotech Stocks Under Review -- Novavax, Gilead Sciences, Ariad Pharma, and Exelixis (PR Newswire)
07.09.16	CERC Data Due Dec., SAMURAI Brings Cheer To CLCD, TNXP Slumps As Study Fails (RTTNews)
25.07.16	D-Day For TBRA, Nicox Falls As FDA Rejects Vesneo, EXEL Awaits EMA Decision (RTTNews)
24.05.16	EXEL Rises On Trial Data, XNPT Agrees To Be Acquired, NVO Faces FDA Panel Today (RTTNews)
26.04.16	AZN Breathes Easy, EXEL Scores FDA Nod, SRPT Disappointed, PETX On The Rise (RTTNews)
29.01.16	Data Due Mid Year For CORT, New Addition To HCV Armory, EXEL Gets FDA Date (RTTNews)
05.01.16	MÄRKTE USA/Keine Erholung von Vortageseinbruch bei Aktien (Dow Jones)
05.01.16	MÄRKTE USA/Erholung von Vortageseinbruch bei Aktien nicht zu erwarten (Dow Jones)
05.01.16	EXEL Shines On Meteor Impact, GILD Gets FDA Date, VCEL Moving Ahead (RTTNews)
27.11.15	AMGN In The Race For Humira Biosimilar, EXEL On Watch, IPXL Gets EC Nod (RTTNews)
11.11.15	FDA Okays Genentech's Cotellic In Combination With Zelboraf In Advanced Melanoma (RTTNews)
06.10.15	Exelixis Announces Positive Overall Survival Results From CoBRIM - Quick Facts (RTTNews)
25.08.15	GALE Climbs On IDMC's Guidance, NAVB Seeks Dual Listing, OCAT Gets Funds (RTTNews)
11.08.15	Exelixis Q2 Loss Narrows - Quick Facts (RTTNews)
22.07.15	Exelixis Plans 20 Mln. Stock Offering (RTTNews)
21.07.15	BMRN Expands Breast Cancer Trial, EXEL's Meteor Shines, HZNP Widens Horizons (RTTNews)
20.07.15	Pre-market Movers For July 20 (MS, HAS, EXEL, HAL, VSLR, LMT, UTX, CALM) (RTTNews)
20.07.15	Exelixis Records Modest Progression-free Survival In Phase 3 METEOR Trial (RTTNews)
01.07.15	Exelixis: FDA Extends PDUFA Action Date For Review Of NDA For Cobimetinib (RTTNews)
31.05.15	Exelixis: Phase 2 Trial Of Cabozantinib Meets Primary Endpoint (RTTNews)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
10.04.15	Medicines Tastes Bitter, EXEL Excels, ORPN Has A Blast, FWP For The Long Haul (RTTNews)
19.02.15	Exelixis: FDA Accepts For Review Genentech NDA For Cobimetinib With Vemurafenib (RTTNews)
07.01.15	Exelixis, Sobi Extend & Restructure Distribution Agreement For COMETRIQ (RTTNews)
15.12.14	Genentech Submits NDA For Cobimetinib With Zelboraf To Treat Advanced Melanoma (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

30.10.24		Anleger in New York halten sich zurück: NASDAQ Composite gibt zum Handelsende nach
30.10.24		Handel in New York: NASDAQ Composite verbucht Verluste
30.10.24		Gute Stimmung in New York: NASDAQ Composite mittags fester
30.10.24		Mittwochshandel in New York: NASDAQ Composite beginnt Mittwochssitzung in der Gewinnzone
15.10.24		Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein
15.10.24		Schwacher Handel: NASDAQ Composite zeigt sich leichter
15.10.24		Dienstagshandel in New York: NASDAQ Composite gibt nach
18.09.24		Angespannte Stimmung in New York: NASDAQ Composite präsentiert sich mittags schwächer

30.10.24

Anleger in New York halten sich zurück: NASDAQ Composite gibt zum Handelsende nach

30.10.24

Handel in New York: NASDAQ Composite verbucht Verluste

30.10.24

Gute Stimmung in New York: NASDAQ Composite mittags fester

30.10.24

Mittwochshandel in New York: NASDAQ Composite beginnt Mittwochssitzung in der Gewinnzone

15.10.24

Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein

15.10.24

Schwacher Handel: NASDAQ Composite zeigt sich leichter

15.10.24

Dienstagshandel in New York: NASDAQ Composite gibt nach

18.09.24

Angespannte Stimmung in New York: NASDAQ Composite präsentiert sich mittags schwächer

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	548.20	4.94 %	K V
CieFinRichemont	135.60	1.46 %	K V
UBS Group	28.62	1.13 %	K V
Holcim	90.18	1.08 %	K V
Alcon	76.56	0.63 %	K V
Swiss Re	127.80	-0.31 %	K V
Sika	230.60	-0.60 %	K V
Swiss Life Hldg	687.20	-0.66 %	K V
Part Grp Hldg	1’284.50	-0.96 %	K V
Kuehne+Nagel Int	205.00	-2.80 %	K V

Nachrichten zu Exelixis Inc.

Aktien Top/Flop

Exelixis Peer Group Nachrichten

Meistgelesene Nachrichten